Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05575479 · ClinicalTrials.gov registry record
PA Behavior and HRQoL in Parkinson's Disease Patients Patients: Role of Social Cognitive Variables
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 500
- Enrollment target
NCT05575479: Completed study, sponsored by Ohio State University.
NCT05575479 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05575479 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
The primary aim of the study will be to examine Social Cognitive Theory (SCT) correlates, of physical activity (PA) participation and health-related quality of life (HRQoL) in Parkinson's disease participants.
Primary Outcome
multiple linear regression analysis will be used to determine if higher HRQoL is significantly related to self-reported physical activity in PD patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2015-08 |
| Est. Completion | 2015-10 |
What the finished NCT05575479 record still lists
NCT05575479 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05575479 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05575479 about?
NCT05575479 is a clinical study titled "PA Behavior and HRQoL in Parkinson's Disease Patients Patients: Role of Social Cognitive Variables". The primary aim of the study will be to examine Social Cognitive Theory (SCT) correlates, of physical activity (PA) participation and health-related quality of life (HRQoL) in Parkinson's disease participants.
What is the current status of trial NCT05575479?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2015-08. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT05575479?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia